在基于单细胞RNA测序的肺腺癌中,鉴定与KRAS/TP53共同突变状态相关的瘤异质性
Ying-Hui Ye1, Yu-Ting Zhang2, Yu-Lou Luo3
1Department of Laboratory Medicine, Peking University Shenzhen Hospital Shenzhen 518000, Guangdong, China.
American journal of cancer research
|March 8, 2024
概括
肺腺癌 (LUAD) 中的KRAS/TP53共同突变显著影响瘤微环境和B细胞透. 一个新的七基因风险模型显示,它有望预测LUAD患者的预后.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 肺腺癌 (LUAD) 呈现出显著的异质性,影响瘤的进展和治疗.
- KRAS/TP53共同突变是LUAD中常见的事件,影响其生物行为.
研究的目的:
- 研究KRAS/TP53共同突变状态对LUAD瘤微环境 (TME) 的影响.
- 开发和验证一个新的预测风险模型来预测LUAD的预后.
- 探索MELTF和PLEK2在LUAD细胞入侵和增殖中的作用.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 对LUAD数据集的分析.
- 在TCGA-LUAD数据上使用LASSO回归的预后风险模型的开发.
- 风险模型的内部和外部验证.
- 在体外实验评估MELTF和PLEK2功能的实验.
主要成果:
- KRAS/TP53共同突变状态显著改变了LUAD TME,特别是B细胞透和免疫通路.
- 一个新的七基因风险模型在验证集中显示出强大的预后性能.
- 确定了MELTF和PLEK2作为LUAD细胞入侵和增殖的潜在调节剂.
结论:
- KRAS/TP53共同突变通过编排B细胞和相关途径,影响LUAD预后和TME.
- 开发的风险模型作为LUAD的独立预后因素.
- MELTF和PLEK2显示出作为LUAD预后生物标志物和治疗点的潜力.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...